ACTIVE_NOT_RECRUITING

Virtual Diabetes Group Visits Across Health Systems

Conditions

T2DM (Type 2 Diabetes Mellitus)Hypertension Heart Disease Chronic Stroke Hyperlipidemias Peripheral Vascular Diseases Obesity virtual group visits

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).

Official Title

VIDA: Virtual Diabetes Group Visits Across Health Systems: Randomized Control Trial

Quick Facts

Study Start:2024-05-03

Study Completion:2026-06-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06094491

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Patient at a PARTICIPATING clinic (at least one visit in year prior to first GV) * Type 2 diabetes * ≥ 18 years old * A1C\>8% within 6 months prior to first GV (we will first recruit patients with A1C\>9%, then if spaces still available A1C\>8.5%, then if spaces still available A1C\>8%) * At least one additional cardiovascular condition (hypertension, heart disease, stroke, hyperlipidemia, peripheral vascular disease, or BMI ≥ 30) * English or Spanish speaking * PCP assented to recruiting patient * Patient provides written consent	Pregnancy or breastfeeding Severe psychiatric disorders Active substance abuse Unstable medical conditions Inability to comply with study requirements

Inclusion Criteria

Exclusion Criteria

* Patient at a PARTICIPATING clinic (at least one visit in year prior to first GV)
* Type 2 diabetes
* ≥ 18 years old
* A1C\>8% within 6 months prior to first GV (we will first recruit patients with A1C\>9%, then if spaces still available A1C\>8.5%, then if spaces still available A1C\>8%)
* At least one additional cardiovascular condition (hypertension, heart disease, stroke, hyperlipidemia, peripheral vascular disease, or BMI ≥ 30)
* English or Spanish speaking
* PCP assented to recruiting patient
* Patient provides written consent

Pregnancy or breastfeeding
Severe psychiatric disorders
Active substance abuse
Unstable medical conditions
Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Arshiya Baig, MD

PRINCIPAL_INVESTIGATOR

University of Chicago

Study Locations (Sites)

Access Community Health Network

Chicago, Illinois, 60661

United States

Advocate Health Care

Orland Park, Illinois, 60462

United States

Collaborators and Investigators

Sponsor: University of Chicago

Arshiya Baig, MD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-03

Study Completion Date2026-06-30

Study Record Updates

Study Start Date2024-05-03

Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

virtual group visits

Additional Relevant MeSH Terms

T2DM (Type 2 Diabetes Mellitus)
Hypertension
Heart Disease Chronic
Stroke
Hyperlipidemias
Peripheral Vascular Diseases
Obesity